News
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders.
13d
Charles Schwab Investment Management Inc. acquired a new stake in MBX Biosciences, Inc. (NYSE:MBX – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm acquired 93,311 shares of the ...
I am thrilled to welcome Steve Hoerter to the Company’s Board as an independent director,” said Kent Hawryluk, President and Chief Executive Officer of MBX Biosciences. “As a seasoned leader within ...
The live webcast can be accessed in the investors section of the MBX Biosciences website at https://investors.mbxbio.com/news-events/events. Access to the webcast replay will be available ...
March 26, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq ... 24th Annual Needham Virtual Healthcare Conference Date: Monday, April 7, Chatan Charan, Ph.D. appointed as Senior Vice ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback